News & Updates

Show Multimedia Only

Vedolizumab after resection helps prevent CD recurrence

05 Jan 2025

For patients with Crohn’s disease (CD) who are scheduled to undergo ileocolonic resection, initiating vedolizumab treatment promptly after the procedure has the potential to prevent recurrence, according to the results of the REPREVIO study.

Vedolizumab after resection helps prevent CD recurrence

05 Jan 2025

New UC guideline endorses early use of advanced therapies

27 Dec 2024 by

The American Gastroenterological Association (AGA), in an update to its living practice guideline, recommends the early use of advanced therapies for the pharmacological management of moderate-to-severe ulcerative colitis (UC) in adult outpatients.

New UC guideline endorses early use of advanced therapies

27 Dec 2024

KEYNOTE-811: Add-on pembrolizumab improves OS in HER2+ gastroesophageal cancer

27 Dec 2024 by

Adding pembrolizumab to trastuzumab and chemotherapy significantly improves overall survival (OS) in patients with advanced unresectable or metastatic HER2+ gastric/gastroesophageal junction (G/GEJ) adenocarcinoma and in those with PD-L1 CPS ≥1, according to the protocol-specified final OS analysis of the KEYNOTE-811 trial presented at ESMO Asia 2024.

KEYNOTE-811: Add-on pembrolizumab improves OS in HER2+ gastroesophageal cancer

27 Dec 2024

Hitting OS endpoint reaffirms frontline daratumumab-VCd as SoC for AL amyloidosis

27 Dec 2024 by

The evidence supporting an upfront daratumumab-containing regimen as the SoC for AL amyloidosis is reaffirmed by the significant OS benefit demonstrated in the final analysis of ANDROMEDA

Hitting OS endpoint reaffirms frontline daratumumab-VCd as SoC for AL amyloidosis

27 Dec 2024

PPI use raises risk of intestinal Behçet disease

24 Dec 2024

Treatment with proton pump inhibitors (PPIs) may contribute to a higher incidence of intestinal Behçet Disease (BD) in patients with BD, suggest the results of a study.

PPI use raises risk of intestinal Behçet disease

24 Dec 2024

Newer hepatitis B vaccine provides superior protection for people with HIV

23 Dec 2024 by

People living with HIV who have no history of hepatitis B virus (HBV) infection or documented response to vaccination appear to have a stronger immune response to the hepatitis B vaccine with a cytosine phosphoguanine adjuvant (HepB-CpG) than that with an aluminum hydroxide adjuvant (HepB-alum).

Newer hepatitis B vaccine provides superior protection for people with HIV

23 Dec 2024

Novel small-molecule modulator for coeliac disease promising in phase 1 trial

23 Dec 2024

The orally available and systemically acting small molecule modulator of sirtuin 6 (SIRT6) IMU-856 for coeliac disease demonstrates clinical activity with favourable safety profile, according to data from a phase 1 trial.

Novel small-molecule modulator for coeliac disease promising in phase 1 trial

23 Dec 2024

Pancreatitis rare after EUS-guided fine-needle aspiration

20 Dec 2024 by

Pancreatitis seldom occurs following endoscopic ultrasound (EUS)-guided fine-needle aspiration (FNA) of pancreatic cystic lesions, but when it does, the severity is usually mild, with no cases of death.

Pancreatitis rare after EUS-guided fine-needle aspiration

20 Dec 2024

Is there a link between mental disorders and IBD?

16 Dec 2024 by

Several analyses presented at AIBD 2024 reflect an association between mental disorders and inflammatory bowel disease (IBD).

Is there a link between mental disorders and IBD?

16 Dec 2024

Elafibranor improves transplant-free survival in patients with PBC

14 Dec 2024 by

Among patients with primary biliary cholangitis (PBC), treatment with elafibranor improved predicted transplant-free survival rates based on improvements in GLOBE and UK-PBC scores, according to the phase III ELATIVE trial presented at The Liver Meeting 2024.

Elafibranor improves transplant-free survival in patients with PBC

14 Dec 2024

News & Updates

Filter by Specialty:

Specialty:

Vedolizumab after resection helps prevent CD recurrence

Vedolizumab after resection helps prevent CD recurrence

New UC guideline endorses early use of advanced therapies

New UC guideline endorses early use of advanced therapies

KEYNOTE-811: Add-on pembrolizumab improves OS in HER2+ gastroesophageal cancer

KEYNOTE-811: Add-on pembrolizumab improves OS in HER2+ gastroesophageal cancer

Hitting OS endpoint reaffirms frontline daratumumab-VCd as SoC for AL amyloidosis

Hitting OS endpoint reaffirms frontline daratumumab-VCd as SoC for AL amyloidosis

PPI use raises risk of intestinal Behçet disease

PPI use raises risk of intestinal Behçet disease

Newer hepatitis B vaccine provides superior protection for people with HIV

Newer hepatitis B vaccine provides superior protection for people with HIV

Novel small-molecule modulator for coeliac disease promising in phase 1 trial

Novel small-molecule modulator for coeliac disease promising in phase 1 trial

Pancreatitis rare after EUS-guided fine-needle aspiration

Pancreatitis rare after EUS-guided fine-needle aspiration

Is there a link between mental disorders and IBD?

Is there a link between mental disorders and IBD?

Elafibranor improves transplant-free survival in patients with PBC

Elafibranor improves transplant-free survival in patients with PBC